Chinese population may require further venetoclax dose reduction beyond guidelines when combined with voriconazole: real-world evidence from China

Chinese population may require further dose reduction of VEN beyond guideline recommendations when combined with VOR.

Authors

Xiangjin Zheng
Shu Li (ORCID: https://orcid.org/0000-0002-9779-5772)
Ren Yuan
Rongrong Wang (ORCID: https://orcid.org/0009-0003-9452-6838)
Ran Zhang (ORCID: https://orcid.org/0000-0002-0921-078X)
Wu Jin (ORCID: https://orcid.org/0000-0002-9492-4751)
Yanfen Li (ORCID: https://orcid.org/0000-0003-0945-591X)
Tianlin Wang (ORCID: https://orcid.org/0000-0001-7555-7389)
Jing Yu (ORCID: https://orcid.org/0000-0003-2234-8959)
Yifan Liu (ORCID: https://orcid.org/0000-0002-6406-4252)